Your browser doesn't support javascript.
loading
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound.
Janoschka, Claudia; Lindner, Maren; Koppers, Nils; Starost, Laura; Liebmann, Marie; Eschborn, Melanie; Schneider-Hohendorf, Tilman; Windener, Farina; Schafflick, David; Fleck, Ann-Katrin; Koch, Kathrin; Deffner, Marie; Schwarze, Anna-Sophie; Schulte-Mecklenbeck, Andreas; Metz, Imke; Meuth, Sven G; Gross, Catharina C; Meyer Zu Hörste, Gerd; Schwab, Nicholas; Kuhlmann, Tanja; Wiendl, Heinz; Stoll, Monika; Klotz, Luisa.
Afiliación
  • Janoschka C; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
  • Lindner M; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
  • Koppers N; Institute of Human Genetics, Genetic Epidemiology, University of Münster, Münster, 48149, Germany.
  • Starost L; Institute for Neuropathology, University of Münster, Münster, 48149, Germany.
  • Liebmann M; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
  • Eschborn M; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
  • Schneider-Hohendorf T; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
  • Windener F; Institute for Neuropathology, University of Münster, Münster, 48149, Germany.
  • Schafflick D; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
  • Fleck AK; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
  • Koch K; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
  • Deffner M; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
  • Schwarze AS; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
  • Schulte-Mecklenbeck A; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
  • Metz I; Institute of Neuropathology, University Medical Center, Georg August University, Göttingen, 37073, Germany.
  • Meuth SG; Department of Neurology, University Hospital Düsseldorf, Düsseldorf, 40225, Germany.
  • Gross CC; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
  • Meyer Zu Hörste G; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
  • Schwab N; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
  • Kuhlmann T; Institute for Neuropathology, University of Münster, Münster, 48149, Germany.
  • Wiendl H; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
  • Stoll M; Institute of Human Genetics, Genetic Epidemiology, University of Münster, Münster, 48149, Germany.
  • Klotz L; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster 48149, Germany.
Proc Natl Acad Sci U S A ; 120(1): e2209944120, 2023 01 03.
Article en En | MEDLINE | ID: mdl-36574650
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Th17 / Esclerosis Múltiple Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Th17 / Esclerosis Múltiple Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos